In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.
Vaccine-preventable diseases – including measles and diphtheria – have surged in crisis-hit Venezuela, according to research presented at ECCMID.
A new population-based survey has reported that low levels of public trust could have impacted the Ebola control efforts in the Democratic Republic of Congo, with a quarter of individuals not believing the virus was real and refusing vaccination.
Recently, many programs developing respiratory syncytial virus vaccines have sought to vaccinate pregnant women in an effort to enhance maternal immunity. Find out about the challenges and the latest developments.
Ethically possible and ethically required: The path towards equitable inclusion of pregnant women in vaccine development
Vaccination during pregnancy provides important benefits, so why are pregnant women excluded from clinical trials? Learn more about the path towards including this group in vaccine development for both routine and emergency vaccinations.
Researchers from the Wistar Institute have engineered a synthetic DNA vaccine able to provide potent immunity against the emerging Mayaro virus in mice models.
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.